Related references
Note: Only part of the references are listed.SEQHEPB: A sequence analysis program and relational database system for chronic hepatitis B
Lilly K. W. Yuen et al.
ANTIVIRAL RESEARCH (2007)
Hepatitis B in the HIV-coinfected patient
Yves Benhamou
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
Stephanos J. Hadziyannis et al.
GASTROENTEROLOGY (2006)
Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127
Marion G. Peters et al.
HEPATOLOGY (2006)
Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection
Guenther Schmutz et al.
AIDS (2006)
Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization
Voranush Chongsrisawat et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2006)
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy
GV Matthews et al.
AIDS (2006)
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
TT Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Anti-hepatitis B virus efficacy of tendovir disoproxil fumarate in HIV-infected patients
Y Benhamou et al.
HEPATOLOGY (2006)
BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis B virus infection (2005)
MG Brook et al.
HIV MEDICINE (2005)
Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
GKK Lau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Liver disease as a major cause of death among HIV infected patients:: role of hepatitis C and B viruses and alcohol
D Salmon-Ceron et al.
JOURNAL OF HEPATOLOGY (2005)
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort
D Konopnicki et al.
AIDS (2005)
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised
HLA Janssen et al.
LANCET (2005)
Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus
GJ Dore et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Immune restoration disease after antiretroviral therapy
MA French et al.
AIDS (2004)
Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome
M Puoti et al.
AIDS (2004)
Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort
WP Law et al.
AIDS (2004)
An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals
M Nelson et al.
AIDS (2003)
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
CL Thio et al.
LANCET (2002)
Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine
M Núñez et al.
AIDS (2002)
Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection
MS Sulkowski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
